IPI International Pharmaceutical Industry

Peer Reviewed, Contemporary, Authoritative

BIOCORP 11 : 16 am
AirBridgeCargo Airlines 10 : 58 am
Constantia Flexibles Pharma 4 : 05 pm
Cobra Biologics: Contract Manufacturing Excellence 9 : 18 am
Biopharma Group 1 : 54 pm

→

The BioRegion of Catalonia: What’s Behind the European Country with More Pharma Companies per Capita?

Jan 4, 2018

Last autumn, Barcelona hosted the CPhI Worldwide for the first time, and it was a record-breaking year for the event. In their article, Nuria Pelaez, Anna Rovira and

The Rise of Cellular Immunotherapy and Global IP Strategies

Jan 4, 2018

We are at the beginning of a new age in cancer therapy. With a large and growing number of patents and applications in this space, we can expect

Preparing for IDMP: The Latest Advice on How to Ensure a Smooth Transition

Jan 4, 2018

The forthcoming ISO IDMP standards governing pharmaceutical product information recording have far-reaching implications for the way companies capture, collate, organise and report a very wide range of operational

Expanding Markets: Where Next? A Regional Regulatory Roundup

Jan 4, 2018

Globalisation and the growing efforts to standardise submission requirements and formats internationally continue to open up new markets for life sciences companies. Yet, there are still significant differences

Got Diversity? Of Course You Do. Now, What Are You Going to Do With It?

Jan 4, 2018

In her piece, Rosalie Harrison, an International Management Consultant with Borderless, addresses the benefits of inclusion & diversity. She tells us that inclusion is the method in which

Quality by Design in the Development: Benefit or Bureaucratic Burden?

Jan 4, 2018

Petra Botzem and Dr Thomas Hille of LTS Lohmann answer this provoking question in their paper on the ICH guideline Q8, with focus on Transdermal Delivery Systems (TDS)

Accurate Protein Electrostatics Add a New Dimension to Structure-based Drug Design

Jan 4, 2018

The combination of advanced molecular force fields and improved visualisation capabilities has enabled chemists to expand their ligand-only view of the electrostatics of their system to include proteins,

Early Interventions to Reduce the Impact of Immunogenicity on the Development of Biopharmaceuticals

Jan 4, 2018

The development of biological therapeutics has led to remarkable clinical benefits in many indications. But, despite this success, the induction of anti-drug antibodies (ADAs) due to the potential

Needle-free Injection – Eradicating Diseases to Improve Global Health

Jan 4, 2018

Needle-free injection technology has evolved significantly over the last 50 years and is now accepted in many routine immunisation settings as a safe and effective vaccine delivery method.

Automated Accountability: Maintaining a Chain of Custody from Release to Destruction

Jan 4, 2018

New solutions are proliferating to improve the efficiency of the clinical research function within pharmaceutical companies and CROs. In her article, Theodora Sarver of Almac reviews the challenges

Rethinking the Cold Supply Chain

Jan 4, 2018

Healthcare manufacturers should continually look for ways to optimise their cold-chain packaging. In her article, Susan Li of UPS shows that the benefits of doing so can be

What Clinical Teams Should Know about Changing Trial Logistics and How they will Affect Development – PART 2

Jan 4, 2018

As we shift to what has been described as “an Amazonlike culture”, sponsors want the same opportunity to track shipments in real time and to obtain real-time data

Strategies for Developing a Cost-Efficient Pharmaceutical Manufacturing Process

Jan 4, 2018

In their paper, Valdas Jurkauskas and Xiaoyong Fu of STA Pharmaceuticals address the fact that manufacturing process throughput optimisation has become a necessity rather than an option. Only

Inspecting on the Edge – Understanding Punch Tip Wear

Jan 4, 2018

Punch tip edge wear can come from a variety of circumstances and may cause significant production quality-related issues. In their article, Bill Turner and Kevin Queensen of Natoli

What Does the Falsified Medicines Directive (FMD) Mean for SMEs and CMOs; and More Importantly, Are These Organisations Ready?

Jan 4, 2018

The implications of the directive are far-reaching and affect all pharmaceutical manufacturers, regardless of size. As time runs out and the deadline grows ever closer, Christian Taylor of

Designing Smart Integrated Drug Delivery Systems

Jan 4, 2018

Wearable drug delivery technology is a good example of how drug delivery technology providers continue to stay ahead of the curve. In his piece, Graham Reynolds of Global

Why Anti-microbial Protection Remains Crucial in Fight Against Infection

Jan 4, 2018

Strands of potential superbugs are developing all the time, and everything must be done to ensure they don’t become a topic of hot – and daunting – conversation